Feasibility of clinical pharmacist-led CYP2C19 genotyping for patients receiving non-emergent cardiac catheterization in an integrated health system

OBJECTIVE: To assess the feasibility of clinical pharmacist-led CYP2C19 genotype-guided P2Y(12) inhibitor antiplatelet drug therapy recommendations to cardiologists in an outpatient cardiology practice. METHODS: This was a prospective, open-labeled, single-arm study conducted in an integrated health...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Samuel G., Shaw, Paul B., Delate, Thomas, Kurz, Deanna L., Gregg, Dylon, Darnell, John C., Aquilante, Christina L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Investigaciones y Publicaciones Farmaceuticas 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499354/
https://www.ncbi.nlm.nih.gov/pubmed/28690699
http://dx.doi.org/10.18549/PharmPract.2017.02.946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499354/
https://www.ncbi.nlm.nih.gov/pubmed/28690699
http://dx.doi.org/10.18549/PharmPract.2017.02.946

Ejemplares similares